Literature DB >> 10494127

Allele-specific polymerase chain reaction for genotyping human cytochrome P450 2E1.

T Sohda1.   

Abstract

Allele-specific polymerase chain reaction (AS-PCR) was applied to investigate the cytochrome P450 2E1 (CYP2E1) genotype. AS-PCR is a competitive multiplex PCR method in which PCR amplification is successfully performed only by using the sequence of 3' oligonucleotide ends as a DNA template in order to obtain an absolutely complementary product. I was able to produce allele-specific primers whose 3' ends had the base specific to Pst I polymorphism located within the 5'-flanking region of the CYP2E1 gene. Electrophoresis of the products showed that bands derived from common PCR products, allele C1 and C2, were clearly separate from each other due to the difference in the size of the products. I tested 102 unrelated Japanese individuals, and the results of both restriction fragment length polymorphism (RFLP) by Pst I or Rsa I and direct sequencing were in complete agreement with those of AS-PCR. These results lead me to conclude that AS-PCR is a simple and useful technique for investigating CYP2E1 genotype. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10494127      PMCID: PMC6807827     

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  14 in total

1.  CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan.

Authors:  A Hildesheim; L M Anderson; C J Chen; Y J Cheng; L A Brinton; A K Daly; C D Reed; I H Chen; N E Caporaso; M M Hsu; J Y Chen; J R Idle; R N Hoover; C S Yang; S K Chhabra
Journal:  J Natl Cancer Inst       Date:  1997-08-20       Impact factor: 13.506

2.  Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk.

Authors:  S Kato; P G Shields; N E Caporaso; R N Hoover; B F Trump; H Sugimura; A Weston; C C Harris
Journal:  Cancer Res       Date:  1992-12-01       Impact factor: 12.701

3.  Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene.

Authors:  S Hayashi; J Watanabe; K Kawajiri
Journal:  J Biochem       Date:  1991-10       Impact factor: 3.387

4.  Lack of association of cytochrome P450 2E1 genetic polymorphisms with the risk of human hepatocellular carcinoma.

Authors:  H S Lee; J H Yoon; S Kamimura; K Iwata; H Watanabe; C Y Kim
Journal:  Int J Cancer       Date:  1997-05-29       Impact factor: 7.396

5.  Polymorphism of alcohol-metabolizing genes affects drinking behavior and alcoholic liver disease in Japanese men.

Authors:  F Tanaka; Y Shiratori; O Yokosuka; F Imazeki; Y Tsukada; M Omata
Journal:  Alcohol Clin Exp Res       Date:  1997-06       Impact factor: 3.455

6.  RsaI polymorphism at the cytochrome P4502E1 locus and risk of hepatocellular carcinoma.

Authors:  J M Ladero; J A Agúndez; A Rodríguez-Lescure; M Diaz-Rubio; J Benítez
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

7.  Metabolism of nitrosamines by purified rabbit liver cytochrome P-450 isozymes.

Authors:  C S Yang; Y Y Tu; D R Koop; M J Coon
Journal:  Cancer Res       Date:  1985-03       Impact factor: 12.701

8.  Purification and characterization of human liver cytochrome P-450-ALC.

Authors:  J M Lasker; J Raucy; S Kubota; B P Bloswick; M Black; C S Lieber
Journal:  Biochem Biophys Res Commun       Date:  1987-10-14       Impact factor: 3.575

9.  Genetic polymorphism of N-acetyltransferase-2, glutathione S-transferase-M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer.

Authors:  M V González; V Alvarez; M F Pello; M J Menéndez; C Suárez; E Coto
Journal:  J Clin Pathol       Date:  1998-04       Impact factor: 3.411

10.  Human ethanol-inducible P450IIE1: complete gene sequence, promoter characterization, chromosome mapping, and cDNA-directed expression.

Authors:  M Umeno; O W McBride; C S Yang; H V Gelboin; F J Gonzalez
Journal:  Biochemistry       Date:  1988-12-13       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.